Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case report

被引：41
|
作者：
So, Brian J. [1 ]
Bekaii-Saab, Tanios [1 ]
Bloomston, Mark A. [1 ]
Patel, Tushar [1 ]
机构：
[1] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF HEMATOLOGY & ONCOLOGY | 2008年 / 1卷 / 1期
关键词：
Renal Cell Carcinoma; Complete Remission; Sorafenib; Gastrointestinal Stromal Tumor; Hemochromatosis;
D O I：
10.1186/1756-8722-1-18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Hepatocellular carcinoma is rare, but increasing in prevalence in the United States. Recent studies have shown that sorafenib, a multikinase inhibitor, can reduce tumor progression in patients with this cancer. However, complete remission has not been observed. We report a case of a 78-year old patient with unresectable metastatic hepatocellular carcinoma who had a rapid and complete clinical response following therapy with sorafenib for six months. No evidence of disease recurrence has been noted for 6 months after discontinuation of therapy.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART ? A case report
    Chelis, Leonidas
    Ntinos, Napoleon
    Souftas, Vasilios
    Deftereos, Savas
    Xenidis, Nikolaos
    Chamalidou, Elen
    Maltezos, Eustratios
    Kakolyris, Stylianos
    MEDICAL ONCOLOGY, 2011, 28 : S165 - S168
  • [32] Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART ? A case report
    Leonidas Chelis
    Napoleon Ntinos
    Vasilios Souftas
    Savas Deftereos
    Nikolaos Xenidis
    Elen Chamalidou
    Eustratios Maltezos
    Stylianos Kakolyris
    Medical Oncology, 2011, 28 : 165 - 168
  • [33] Exacerbation of Psoriasis with Pustulation by Sorafenib in a Patient with Metastatic Hepatocellular Carcinoma
    Ohashi, Takenobu
    Yamamoto, Toshiyuki
    INDIAN JOURNAL OF DERMATOLOGY, 2019, 64 (01) : 75 - +
  • [34] Sorafenib-Induced Interstitial Pneumonitis in a Patient with Hepatocellular Carcinoma: A Case Report
    Myung, Hyung-Joon
    Jeong, Sook-Hyang
    Kim, Jin-Wook
    Kim, Hee-Sup
    Jang, Je-Hyuck
    Yoon, Ho Il
    Kim, Jae-Sung
    GUT AND LIVER, 2010, 4 (04) : 543 - 546
  • [35] Hyperkalemia in a Patient with Advanced Hepatocellular Carcinoma Probably Due to Sorafenib: Case Report
    Uyeturk, Ummugul
    Budakoglu, Burcin
    Helvaci, Kaan
    Sonmez, Ozlem Uysal
    Turker, Ibrahim
    Arslan, Ulku Yalcintas
    Oksuzoglu, Berna
    Zengin, Nurullah
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32 (02): : 585 - 587
  • [36] Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenib
    Lulla P.D.
    Brammer J.E.
    Bandeali S.
    Lynch G.R.
    Journal of Gastrointestinal Cancer, 2013, 44 (1) : 98 - 101
  • [37] Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report
    Yamaguchi, Takashi
    Seki, Toshihito
    Miyasaka, Chika
    Inokuchi, Ryosuke
    Kawamura, Rinako
    Sakaguchi, Yuutaku
    Murata, Miki
    Matsuzaki, Koichi
    Nakano, Yorika
    Uemura, Yoshiko
    Okazaki, Kazuichi
    ONCOLOGY LETTERS, 2015, 9 (04) : 1633 - 1636
  • [38] Prolong survival with complete resolution of hepatocellular carcinoma following sorafenib therapy - case report
    Azmi, Ahmad Najib
    Goh, Khean Lee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 249 - 250
  • [39] Complete pathological remission after palliative therapy with sorafenib in hepatocellular carcinoma - case report
    Lebiedzinska, Aneta
    Sigorski, Dawid
    Michalak, Maciej
    Kozielec, Zygmunt
    Doboszynska, Anna
    Zadrozny, Dariusz
    Rozanowski, Pawel
    ONCOLOGY IN CLINICAL PRACTICE, 2019, 15 (02): : 127 - 131
  • [40] Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report
    Wang, Sean Xiang
    Byrnes, Abigail
    Verma, Sadhna
    Pancoast, John R.
    Rixe, Olivier
    TARGETED ONCOLOGY, 2010, 5 (01) : 59 - 63
12345